Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 29

1.

Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.

Walsh KS, Vélez JI, Kardel PG, Imas DM, Muenke M, Packer RJ, Castellanos FX, Acosta MT.

Dev Med Child Neurol. 2013 Feb;55(2):131-8. doi: 10.1111/dmcn.12038. Epub 2012 Nov 16.

PMID:
23163951
[PubMed - indexed for MEDLINE]
2.

Attention-deficit/Hyperactivity Disorder in the context of Autism spectrum disorders.

Murray MJ.

Curr Psychiatry Rep. 2010 Oct;12(5):382-8. doi: 10.1007/s11920-010-0145-3. Review.

PMID:
20694583
[PubMed - indexed for MEDLINE]
3.

Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.

Mahajan R, Bernal MP, Panzer R, Whitaker A, Roberts W, Handen B, Hardan A, Anagnostou E, Veenstra-VanderWeele J; Autism Speaks Autism Treatment Network Psychopharmacology Committee.

Pediatrics. 2012 Nov;130 Suppl 2:S125-38. doi: 10.1542/peds.2012-0900J. Review.

PMID:
23118243
[PubMed - indexed for MEDLINE]
Free Article
4.

[Autism and ADHD across the life span. Differential diagnoses or comorbidity?].

Banaschewski T, Poustka L, Holtmann M.

Nervenarzt. 2011 May;82(5):573-80. doi: 10.1007/s00115-010-3239-6. Review. German.

PMID:
21484168
[PubMed - indexed for MEDLINE]
5.

Effectiveness of nutritional interventions on the functioning of children with ADHD and/or ASD. An updated review of research evidence.

Martí LF.

Bol Asoc Med P R. 2010 Oct-Dec;102(4):31-42. Review.

PMID:
21766545
[PubMed - indexed for MEDLINE]
6.

Autism spectrum disorders, attention deficit/hyperactivity disorder, and sleep disorders.

Ming X, Walters AS.

Curr Opin Pulm Med. 2009 Nov;15(6):578-84. doi: 10.1097/MCP.0b013e3283319a9a. Review.

PMID:
19713848
[PubMed - indexed for MEDLINE]
7.

Psychopharmacological treatment of ADHD symptoms in children with autism spectrum disorder.

Handen BL, Taylor J, Tumuluru R.

Int J Adolesc Med Health. 2011;23(3):167-73. Review.

PMID:
22191179
[PubMed - indexed for MEDLINE]
8.

Treatment for co-occurring attention deficit/hyperactivity disorder and autism spectrum disorder.

Davis NO, Kollins SH.

Neurotherapeutics. 2012 Jul;9(3):518-30. doi: 10.1007/s13311-012-0126-9. Review.

PMID:
22678458
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Neurofibromatosis type 1: new insights into neurocognitive issues.

Acosta MT, Gioia GA, Silva AJ.

Curr Neurol Neurosci Rep. 2006 Mar;6(2):136-43. Review.

PMID:
16522267
[PubMed - indexed for MEDLINE]
10.

Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder.

Bradstreet JJ, Smith S, Baral M, Rossignol DA.

Altern Med Rev. 2010 Apr;15(1):15-32. Review.

PMID:
20359266
[PubMed - indexed for MEDLINE]
Free Article
11.

[Attention-deficit / hyperactivity disorder in autism spectrum disorders].

Montiel-Nava C, Peña JA.

Invest Clin. 2011 Jun;52(2):195-204. Review. Spanish.

PMID:
21866791
[PubMed - indexed for MEDLINE]
12.

Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence.

Lehtonen A, Howie E, Trump D, Huson SM.

Dev Med Child Neurol. 2013 Feb;55(2):111-25. doi: 10.1111/j.1469-8749.2012.04399.x. Epub 2012 Aug 31. Review.

PMID:
22934576
[PubMed - indexed for MEDLINE]
13.

[Psychiatric issues of children and adults with autism spectrum disorders who remain undiagnosed].

Kamio Y, Moriwaki A, Takei R, Inada N, Inokuchi E, Takahashi H, Nakahachi T.

Seishin Shinkeigaku Zasshi. 2013;115(6):601-6. Review. Japanese.

PMID:
23944117
[PubMed - indexed for MEDLINE]
14.

Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan.

Doyle CA, McDougle CJ.

Dialogues Clin Neurosci. 2012 Sep;14(3):263-79. Review.

PMID:
23226952
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The spectrum of the behavioral phenotype in boys and adolescents 47,XXY (Klinefelter syndrome).

Tartaglia N, Cordeiro L, Howell S, Wilson R, Janusz J.

Pediatr Endocrinol Rev. 2010 Dec;8 Suppl 1:151-9. Review.

PMID:
21217607
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Research review: Social motivation and oxytocin in autism--implications for joint attention development and intervention.

Stavropoulos KK, Carver LJ.

J Child Psychol Psychiatry. 2013 Jun;54(6):603-18. doi: 10.1111/jcpp.12061. Epub 2013 Mar 2. Review.

PMID:
23451765
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A neuropsychological perspective on attention problems in neurofibromatosis type 1.

Templer AK, Titus JB, Gutmann DH.

J Atten Disord. 2013 Aug;17(6):489-96. doi: 10.1177/1087054711433422. Epub 2012 Feb 21. Review.

PMID:
22354384
[PubMed - indexed for MEDLINE]
18.

Pharmacotherapy of autism spectrum disorders.

Benvenuto A, Battan B, Porfirio MC, Curatolo P.

Brain Dev. 2013 Feb;35(2):119-27. doi: 10.1016/j.braindev.2012.03.015. Epub 2012 Apr 25. Review.

PMID:
22541665
[PubMed - indexed for MEDLINE]
19.

Visual processing and learning disorders.

Koller HP.

Curr Opin Ophthalmol. 2012 Sep;23(5):377-83. doi: 10.1097/ICU.0b013e32835720e2. Review.

PMID:
22847031
[PubMed - indexed for MEDLINE]
20.

Behavioural outcomes and psychopathology during adolescence.

Johnson S, Wolke D.

Early Hum Dev. 2013 Apr;89(4):199-207. doi: 10.1016/j.earlhumdev.2013.01.014. Epub 2013 Feb 27. Review.

PMID:
23455605
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk